|
Gilead Sciences Announces First Quarter 2011 Financial Results
Insurance News Net (press release) Sales of other products were $147.1 million for the first quarter of 2011 compared to $150.0 million for the first quarter of 2010 and included AmBisome ® (amphotericin B) liposome for injection for the treatment of severe fungal infections, ... |
Read the full story:
Gilead Sciences Announces First Quarter 2011 Financial Results - Insurance News Net (press release)
You must log in to post a comment.